Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

被引：0
|
作者：
P F Ferrucci
S Gandini
A Battaglia
S Alfieri
A M Di Giacomo
D Giannarelli
G C Antonini Cappellini
F De Galitiis
P Marchetti
G Amato
A Lazzeri
L Pala
E Cocorocchio
C Martinoli
机构：
[1] Medical Oncology of Melanoma Unit,Division of Epidemiology and Biostatistics
[2] European Institute of Oncology,Medical Oncology and Immunotherapy Division
[3] European Institute of Oncology,IV Oncology Division
[4] University Hospital of Siena,undefined
[5] Scientific Direction,undefined
[6] National Cancer Institute Regina Elena,undefined
[7] Istituto Dermopatico dell’Immacolata IRCCS,undefined
[8] Medical Oncology,undefined
[9] Sant’Andrea Hospital,undefined
来源：
British Journal of Cancer | 2015年 / 112卷
关键词：
neutrophils; lymphocytes; ipilimumab; melanoma; biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1904 / 1910
页数：6
相关论文
共 50 条
  • [1] Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
    Ferrucci, P. F.
    Gandini, S.
    Battaglia, A.
    Alfieri, S.
    Di Giacomo, A. M.
    Giannarelli, D.
    Cappellini, G. C. Antonini
    De Galitiis, F.
    Marchetti, P.
    Amato, G.
    Lazzeri, A.
    Pala, L.
    Cocorocchio, E.
    Martinoli, C.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (12) : 1904 - 1910
  • [2] Prognostic relevance of baseline neutrophils and derived neutrophil to lymphocyte ratio for ipilimumab-treated advanced melanoma patients.
    Ferrucci, Pier Francesco
    Giannarelli, Diana
    Gandini, Sara
    Cocorocchio, Emilia
    Del Vecchio, Michele
    Picasso, Virginia
    Pigozzo, Jacopo
    Di Giacomo, Anna Maria
    Simeone, Ester
    Chiarion-Sileni, Vanna
    Queirolo, Paola
    Maio, Michele
    Ascierto, Paolo Antonio
    Martinoli, Chiara
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Baseline neutrophil-to-lymphocyte ratio and its values monitored over time is associated with outcome of metastatic melanoma patients treated with immunotherapy
    Lugowska, I.
    Cybulska-Stopa, B.
    Jagodzinska-Mucha, P.
    Teterycz, P.
    Kosela-Paterczyk, H.
    Kozak, K.
    Szamotulska, K.
    Roman, K.
    Switaj, T.
    Ziobro, M.
    Rutkowski, P.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [4] Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
    Ferrucci, P. F.
    Ascierto, P. A.
    Pigozzo, J.
    Del Vecchio, M.
    Maio, M.
    Cappellini, G. C. Antonini
    Guidoboni, M.
    Queirolo, P.
    Savoia, P.
    Mandala, M.
    Simeone, E.
    Valpione, S.
    Altomonte, M.
    Spagnolo, F.
    Cocorocchio, E.
    Gandini, S.
    Giannarelli, D.
    Martinoli, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (04) : 732 - 738
  • [5] Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
    E. Cocorocchio
    C. Martinoli
    S. Gandini
    L. Pala
    F. Conforti
    S. Stucchi
    G. Mazzarol
    P. Ferrucci
    [J]. Clinical and Translational Oncology, 2020, 22 : 1818 - 1824
  • [6] Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
    Cocorocchio, E.
    Martinoli, C.
    Gandini, S.
    Pala, L.
    Conforti, F.
    Stucchi, S.
    Mazzarol, G.
    Ferrucci, P.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (10): : 1818 - 1824
  • [7] Baseline neutrophil to lymphocyte ratio as a selection criterion for ipilimumab treatment in metastatic melanoma patients
    Ferrucci, Pier Francesco
    Gandini, Sara
    Battaglia, Angelo
    Alfieri, Salvatore
    Pala, Laura
    Di Giacomo, Annamaria
    Amato, Giovanni
    Cappellini, Gian Carlo Antonini
    Giannarelli, Diana
    Cocorocchio, Emilia
    Martinoli, Chiara
    [J]. CANCER RESEARCH, 2015, 75
  • [8] Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcome in recurrent or metastatic head and neck cancer patients treated with nivolumab
    Ueda, Tsutomu
    Chikuie, Nobuyuki
    Takumida, Masaya
    Furuie, Hiromi
    Kono, Takashi
    Taruya, Takayuki
    Hamamoto, Takao
    Hattori, Minoru
    Ishino, Takashi
    Takeno, Sachio
    [J]. ACTA OTO-LARYNGOLOGICA, 2020, 140 (02) : 181 - 187
  • [9] Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors
    Machet, L.
    Zaragoza, J.
    Finon, A.
    Garnier, M.
    Maillard, H.
    Caille, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 224 - 224
  • [10] High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors
    Teterycz, Pawel
    Jagodzinska-Mucha, Paulina
    Cybulska-Stopa, Bozena
    Mariuk-Jarema, Anna
    Kozak, Katarzyna
    Kosela-Paterczyk, Hanna
    Czarnecka, Anna M.
    Rajczykowski, Marcin
    Dziura, Robert
    Galus, Lukasz
    Mackiewicz, Jacek
    Switaj, Tomasz
    Klimczak, Anna
    Falkowski, Slawomir
    Suwinski, Rafal
    Ziobro, Marek
    Lugowska, Iwona
    Rutkowski, Piotr
    [J]. MELANOMA RESEARCH, 2018, 28 (05) : 435 - 441
12345